Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Apr;99(4):840–844. doi: 10.1111/j.1476-5381.1990.tb13017.x

Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones.

S Vanner 1, A Surprenant 1
PMCID: PMC1917554  PMID: 2141798

Abstract

1. Intracellular recordings were made from neurones of the guinea-pig submucosal plexus. The effects of several 5-hydroxytryptamine3 (5-HT3) receptor antagonists on depolarizations produced by ionophoretic application of 5-HT and acetylcholine, as well as on fast excitatory postsynaptic potentials (fast e.p.s.ps) produced by nerve stimulation were examined. 2. ICS 205-930, GR 38032F, MDL 72222, cocaine and curare all inhibited the fast e.p.s.p. as well as the depolarizations in response to 5-HT and acetylcholine (ACh) ionophoresis in a dose-dependent fashion. 3. IC50 values for ICS 205-930, GR 38032F, MDL 72222, cocaine and curare in inhibiting the 5-HT mediated depolarizations were 12 nM, 100 nM, 3 microM, 3 microM and 20 microM, respectively. 4. IC50 values for ICS 205-930, GR 38032F, MDL 72222, cocaine and curare in inhibiting the nicotinic depolarizations were 4 microM, 12 microM, 11 microM, 6 microM and 17 microM, respectively. Similar IC50 values were obtained for inhibition of the fast e.p.s.ps by these antagonists. 5. The nicotinic receptor blocker, hexamethonium, inhibited the nicotinic depolarization and the fast e.p.s.p. with IC50 values of 10 microM. Hexamethonium (10 microM-5 mM) did not alter the depolarization induced by 5-HT. 6. These results demonstrate that the pharmacological profile of 5-HT3 receptors present on submucosal neurones is identical to that of 5-HT3 receptors on myenteric neurones and, thus, provide evidence that the enteric neuronal 5-HT3 receptor forms a receptor subtype distinct from that characterized in other parts of the autonomic nervous system.

Full text

PDF
840

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akasu T., Tokimasa T. Potassium currents in submucous neurones of guinea-pig caecum and their synaptic modification. J Physiol. 1989 Sep;416:571–588. doi: 10.1113/jphysiol.1989.sp017778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986 Jun;25(6):563–576. doi: 10.1016/0028-3908(86)90207-8. [DOI] [PubMed] [Google Scholar]
  3. Butler A., Hill J. M., Ireland S. J., Jordan C. C., Tyers M. B. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 Jun;94(2):397–412. doi: 10.1111/j.1476-5381.1988.tb11542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen M. L., Bloomquist W., Gidda J. S., Lacefield W. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride. J Pharmacol Exp Ther. 1989 Jan;248(1):197–201. [PubMed] [Google Scholar]
  5. Derkach V., Surprenant A., North R. A. 5-HT3 receptors are membrane ion channels. Nature. 1989 Jun 29;339(6227):706–709. doi: 10.1038/339706a0. [DOI] [PubMed] [Google Scholar]
  6. Elliott P., Wallis D. I. The depolarizing action of 5-hydroxytryptamine on rabbit isolated preganglionic cervical sympathetic nerves. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):608–615. doi: 10.1007/BF00165624. [DOI] [PubMed] [Google Scholar]
  7. Fozard J. R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):36–44. doi: 10.1007/BF00518776. [DOI] [PubMed] [Google Scholar]
  8. Fozard J. R., Mobarok ALI A. T. Blockade of neuronal tryptamine receptors by metoclopramide. Eur J Pharmacol. 1978 May 1;49(1):109–112. doi: 10.1016/0014-2999(78)90228-5. [DOI] [PubMed] [Google Scholar]
  9. Higashi H., Nishi S. 5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia. J Physiol. 1982 Feb;323:543–567. doi: 10.1113/jphysiol.1982.sp014091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirst G. D., Silinsky E. M. Some effects of 5-hydroxytryptamine, dopamine and noradrenaline on neurones in the submucous plexus of guinea-pig small intestine. J Physiol. 1975 Oct;251(3):817–832. doi: 10.1113/jphysiol.1975.sp011124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lambert J. J., Peters J. A., Hales T. G., Dempster J. The properties of 5-HT3 receptors in clonal cell lines studied by patch-clamp techniques. Br J Pharmacol. 1989 May;97(1):27–40. doi: 10.1111/j.1476-5381.1989.tb11920.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lipscombe D., Rang H. P. Nicotinic receptors of frog ganglia resemble pharmacologically those of skeletal muscle. J Neurosci. 1988 Sep;8(9):3258–3265. doi: 10.1523/JNEUROSCI.08-09-03258.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mawe G. M., Branchek T. A., Gershon M. D. Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9799–9803. doi: 10.1073/pnas.83.24.9799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Neijt H. C., Vijverberg H. P., Van den Bercken J. The dopamine response in mouse neuroblastoma cells is mediated by serotonin 5HT3 receptors. Eur J Pharmacol. 1986 Aug 15;127(3):271–274. doi: 10.1016/0014-2999(86)90374-2. [DOI] [PubMed] [Google Scholar]
  15. Neijt H. C., te Duits I. J., Vijverberg H. P. Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells. Neuropharmacology. 1988 Mar;27(3):301–307. doi: 10.1016/0028-3908(88)90048-2. [DOI] [PubMed] [Google Scholar]
  16. Neild T. O. The action of 5-hydroxytryptamine and possible 5-hydroxytryptamine antagonists on neurones of the guinea-pig submucous plexus. Gen Pharmacol. 1981;12(4):281–284. doi: 10.1016/0306-3623(81)90059-8. [DOI] [PubMed] [Google Scholar]
  17. Peroutka S. J. 5-Hydroxytryptamine receptor subtypes. Annu Rev Neurosci. 1988;11:45–60. doi: 10.1146/annurev.ne.11.030188.000401. [DOI] [PubMed] [Google Scholar]
  18. Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985 Jul 11;316(6024):126–131. doi: 10.1038/316126a0. [DOI] [PubMed] [Google Scholar]
  19. Surprenant A., Crist J. Electrophysiological characterization of functionally distinct 5-hydroxytryptamine receptors on guinea-pig submucous plexus. Neuroscience. 1988 Jan;24(1):283–295. doi: 10.1016/0306-4522(88)90331-4. [DOI] [PubMed] [Google Scholar]
  20. Surprenant A., North R. A. Mechanism of synaptic inhibition by noradrenaline acting at alpha 2-adrenoceptors. Proc R Soc Lond B Biol Sci. 1988 Jun 22;234(1274):85–114. doi: 10.1098/rspb.1988.0039. [DOI] [PubMed] [Google Scholar]
  21. Wallis D. I., Dun N. J. A comparison of fast and slow depolarizations evoked by 5-HT in guinea-pig coeliac ganglion cells in vitro. Br J Pharmacol. 1988 Jan;93(1):110–120. doi: 10.1111/j.1476-5381.1988.tb11411.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES